US RNA medicines company Arrowhead Pharmaceuticals (Nasdaq: ARWR) saw its shares rise about 19% after reporting positive top-line results from two pivotal Phase III studies of plozasiran in severe ...

A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...

UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...

USA-based gout specialist Crystalys Therapeutics has closed an oversubscribed $130 million series B financing to fund ...

Less than a month after a US advisory panel voted against it, AstraZeneca's (LSE: AZN) camizestrant has won a positive opinion from Europe's Committee for Medicinal Products for Human Use (CHMP), ...

A Nasdaq-listed biotech advancing bispecific antibodies that simultaneously block paired disease drivers in immunology and ...

US clinical-stage biotech Kairos Pharma saw its shares close down 12.6% at $0.31 yesterday, despite announcing a strategic ...

US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...

A precision neuroscience company rebuilding after three consecutive Phase III failures with navacaprant in major depressive disorder, now pivoting its clinical portfolio toward Alzheimer's agitation, ...

Cambridge Antibody Technology is the latest firm to join the Pfizer-Gen network of alliances, which Pfizer initiated in 1995 to expand its biotechnology expertise. As a result, CAT has signed a ...

A life-sciences startup based in South San Francisco, focused on developing bispecific antibodies for immune and inflammatory diseases. Its discovery platform, DualScreen, enables screening of large ...

Indian pharmaceutical stocks fell sharply on July 22 after US President Donald Trump announced plans to impose steep tariffs ...